Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Harmony Biosciences Holdings (HRMY) Asset Utilization Ratio (2020 - 2025)

Harmony Biosciences Holdings' Asset Utilization Ratio history spans 6 years, with the latest figure at 0.7 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 5.56% year-over-year to 0.7; the TTM value through Dec 2025 reached 0.7, down 5.56%, while the annual FY2025 figure was 0.76, 3.12% down from the prior year.
  • Asset Utilization Ratio for Q4 2025 was 0.7 at Harmony Biosciences Holdings, down from 0.71 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.77 in Q2 2024 and bottomed at 0.52 in Q1 2021.
  • The 5-year median for Asset Utilization Ratio is 0.72 (2021), against an average of 0.71.
  • The largest annual shift saw Asset Utilization Ratio surged 73.26% in 2021 before it dropped 10.27% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.74 in 2021, then dropped by 10.27% to 0.66 in 2022, then increased by 10.19% to 0.73 in 2023, then increased by 1.26% to 0.74 in 2024, then decreased by 5.56% to 0.7 in 2025.
  • Per Business Quant, the three most recent readings for HRMY's Asset Utilization Ratio are 0.7 (Q4 2025), 0.71 (Q3 2025), and 0.71 (Q2 2025).